Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H8N3O3S.Cl |
| Molecular Weight | 273.696 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[O-][N+](=O)C1=CC=C(O1)C2=CSC3=[N+]2CCN3
InChI
InChIKey=FMPJXUZSXKJUQI-UHFFFAOYSA-N
InChI=1S/C9H7N3O3S.ClH/c13-12(14)8-2-1-7(15-8)6-5-16-9-10-3-4-11(6)9;/h1-2,5H,3-4H2;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C9H7N3O3S |
| Molecular Weight | 237.235 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Topical treatment of the burn patient. | 1975-06 |
|
| Induction of delayed hypersensitivity in guinea pigs by aflatoxins, other coumarins and furazolium. | 1970-12 |
|
| Two new topical nitrofurans, furazolium and furazolidone. A therapeutic trial among patients with skin sores. | 1969-09 |
|
| Topical control of water loss from the body surface. 3. The effects of Furazolium Chloride (Novofur) and Furacin on membrane permeability: an in vitro study. | 1969-07 |
|
| Evaluation of furazolium chloride in topical treatment of model infections in laboratory animals. | 1967 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1080358
Unknown
Route of Administration:
Topical
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:26:21 GMT 2025
by
admin
on
Mon Mar 31 21:26:21 GMT 2025
|
| Record UNII |
4L8K79835D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5118-17-2
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | |||
|
C007800
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110940
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | |||
|
C166764
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | |||
|
SUB07835MIG
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | |||
|
100000080677
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | |||
|
m1176
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | Merck Index | ||
|
1918
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | |||
|
68630
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | |||
|
4L8K79835D
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY | |||
|
DTXSID10965454
Created by
admin on Mon Mar 31 21:26:21 GMT 2025 , Edited by admin on Mon Mar 31 21:26:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |